Pharmafile Logo

Souvenaid

- PMLiVE

German drug cost containment system ‘aids data transparency’

New study by IQWiG suggests similar rules should be rolled out across Europe

- PMLiVE

Boehringer steals lead among NOACs with Pradaxa antidote

Has filed reversal agent for European approval

- PMLiVE

PMCPA ‘appalled’ by Chiesi’s Code of Practice breach

Ethics watchdog says firm mislead it in a "completely unacceptable" manner

- PMLiVE

Mersana appoints Anna Protopapas as president and CEO

Joins from Millenium Pharmaceuticals

National Institute for Health and Care Excellence NICE logo

Patients should have a say in their medication, claims NICE

Also states health practitioners should be able to share information

- PMLiVE

Transforming times at AstraZeneca

Lisa Anson, the company’s UK and Ireland president, on AZ's future direction

EU flag

New cancer meds and drug extensions top CHMP recommendations

Drugs for rare disease, oncology and diabetes top regulator’s endorsements

- PMLiVE

Gilead’s Harvoni gains NICE yes – but won’t face funding delay

Unlike the company's Sovaldi, which won’t be paid for until the summer

- PMLiVE

J&J sells Cordis unit to Cardinal Health for $1.94bn

Marks J&J’s exit from the cardiovascular stent market

- PMLiVE

Publicis Healthcare names North America group president

Alexandra von Plato to take up the role

- PMLiVE

Complaints about UK medical advertising drop

And this year the MHRA will be vetting adverts to promote a ‘right first time’ approach

- PMLiVE

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links